| Literature DB >> 12964068 |
Cristina Marchisano-Karpman1, Micheal W DeGregorio.
Abstract
Arzoxifene is a benzothiophene second-generation selective estrogen receptor modulator (SERM) under development by Eli Lilly & Co as a potential treatment for cancer.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12964068
Source DB: PubMed Journal: IDrugs ISSN: 1369-7056